Afuco™ Anti-TGFB1 ADCC Therapeutic Antibody (Fresolimumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to TGF-beta. Fresolimumab (GC1008) is a human monoclonal antibody and an immunomodulator. It is intended for the treatment of idiopathic pulmonary fibrosis (IPF), focal segmental glomerulosclerosis, and cancer (kidney cancer and melanoma).
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-140 |
| Pricing | Inquiry |
| Host | Human |
| Target | TGFB1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | Neut, ELISA, IF, IP, FuncS, FC |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |